DOCSLIB.ORG

Research, Development and Evaluation Strategies for Pharmaceutical Education and the Workforce: a Global Report

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Research, Development and Evaluation Strategies for Pharmaceutical Education and the Workforce: a Global Report Research, development and evaluation strategies for pharmaceutical education and the workforce: A global report 2017 Copyright © 2017 International Pharmaceutical Federation (FIP) 1 | Research, Development and Evaluation Strategies Colophon Copyright© 2017 International Pharmaceutical Federation (FIP) Fédération Internationale Pharmaceutique (FIP) Andries Bickerweg 5 2517 JP The Hague The Netherlands ................www.fip.org - [email protected].............. All rights reserved. No part of this publication may be stored in any retrieval system or transcribed by any form or means — eletronic, mechanical, recording, or otherwise — without citation of the source. FIP shall not be held liable for any damages incurred resulting from the use of any data and information from this report. All measures have been taken to ensure accuracy of the data and information presented in this report. This report is available for electronic download from: www.fip.org/educationreports Editors: Lina R. Bader, FIP Education (FIPEd) Project Coordinator and Researcher Ian Bates, Director of the FIPEd Development Team, FIP-UCL Collaborating Centre, University College London, School of Pharmacy ISBN 978-0-902936-41-6 Design: Tiago Tomé Recommended citation: International Pharmaceutical Federation (FIP). Research, development and evaluation strategies for pharmaceutical education and the workforce: A global report. The Hague: International Pharmaceutical Federation; 2017. Research, Development and Evaluation Strategies | 2 Contents Foreword 3 Executive summary 4 Part 1 Introduction and background 6 Part 2 Progress towards the Pharmaceutical Workforce Development Goals (PWDGs) 9 Part 3 Strategies for advancing the global pharmaceutical workforce agenda 31 3.1 Evaluation and impact for global workforce development 31 3.2 From workforce intelligence to workforce development 37 3.3 Building academic capacity and the academic workforce 40 3.4 Leadership development: preparing the pharmaceutical workforce 45 Part 4 Research and development in technology-driven education 52 Part 5 Summary and conclusions 57 Annexes 59 Annex 1 Pharmaceutical Workforce Development Goals (PWDGs) 59 Annex 2 PWDGs alignment with global health workforce strategies 64 Annex 3 Overview of FIPEd tools 66 Annex 4 Acknowledgements 70 3 | Research, Development and Evaluation Strategies Foreword The International Pharmaceutical Federation (FIP) hosted the first Global Conference on Pharmacy and Pharmaceutical Sciences Education in Nanjing, China, on 7 & 8 November 2016. The global conference was an exceptional event that gathered pharmacy leaders from around the world to create a globally shared vision for transformative pharmacy and pharmaceutical sciences education. Following an extensive consensus-based consultation process, three critical documents that set the future milestones for workforce development through education were adopted at the global conference: (1) a Global Vision for Education and Workforce, (2) Pharmaceutical Workforce Development Goals, and (3) Statements on Pharmacy and Pharmaceutical Sciences Education ("the Nanjing Statements"). The global vision describes the future directions of our profession and how education can support the evolution of science and practice. A set of 13 Pharmaceutical Workforce Development Goals aim to facilitate the implementation of the global vision through a series of measurable, feasible and tangible goals. The Nanjing Statements are a set of 67 statements that describe an envisioned future for education, to enable the enhancement of professional education standards worldwide. A full report of the global conference, “Transforming Pharmacy and Pharmaceutical Sciences Education in the Context of Workforce Development”, was launched in May 2017. Through the report, FIP calls on leaders in pharmacy practice, pharmaceutical education and other key stakeholders to support and advocate the implementation of these key outcomes in their countries. Under the aegis of FIP Education (FIPEd), FIP is committed to inform, guide and support the strategic planning and implementation of the outcomes to facilitate the transformation of the global pharmaceutical workforce in line with overall health workforce strategies promoted by national and international agencies. Research, development and evaluation are key mechanisms for strategy implementation and this report widens the evidence base for research, development and evaluation strategies for pharmaceutical education and the workforce. With evidence-based expert recommendations and comprehensive case studies from 21 countries around the world, the report provides guidance on aligning national research, development and evaluation projects with the global vision and Pharmaceutical Workforce Development Goals. This document is intended for all members of the pharmaceutical workforce, pharmacy leaders, governments and other stakeholders to catalyse needs-based planning, priority setting and forward action towards implementing the global vision. The report is also intended as a tool for member organisations to help prioritise and facilitate the adoption of the Pharmaceutical Workforce Development Goals in the context of their national strategies on health and workforce development. FIPEd — armed with a clear, shared global vision — is committed now more than ever to advance the global pharmaceutical workforce in the context of education and training. The first FIPEd publication following the launch of the Nanjing roadmap, this report aims to enable global action to transform the pharmaceutical workforce in line with the newly adopted global roadmap. William N. Charman, BPharm, PhD FIP Education (FIPEd) Executive Committee Chair Sir John Monash Distinguished Professor Dean, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University Research, Development and Evaluation Strategies | 4 EXECUTIVE SUMMARY 1. Key messages 1.6 The pharmaceutical workforce needs to be continually monitored and assessed in order to evaluate various 1.1 Healthcare access and delivery faces significant capacity challenges; however further work is also global and local challenges; rising demand, increasing needed to develop professional, economic and co-morbidities and demand for medicines expertise disease indicators to better describe the impact of particularly stand out for our profession. Investing in the pharmaceutical workforce. Academic capacity in the scale up of the health workforce around the world particular, and the training of the next generation of to meet this general demand is a clear objective shared scientists and teachers, is an essential component of collectively by the World Health Organization, United these workforce intelligence objectives. Nations agencies, and other global leadership bodies. 1.7 The literature on leadership development in pharmacy 1.2 Research, development and evaluation mechanisms is under-researched and little is known about the are integral to achieving progress on our Global Vision global status of pharmacy leadership strategies; for Education and Workforceª and the Pharmaceutical paradoxically, leadership development remains a Workforce Development Goalsb (PWDGs). Global challenge, and concerted action is required to drive engagement to make research, development and evidence-generation in this area. Country-level evaluation strategies an important consideration leadership bodies should ensure the creation of clear for implementing the pharmaceutical workforce and accessible leadership development programmes development agenda is a critical next step for our and opportunities for their pharmaceutical workforce; profession. this report provides good examples where this has been the case. Additionally, implementation of 1.3 The first FIPEd publication following the launch of the leadership development strategies should integrate Nanjing roadmap, this report starts the discussion with other aspects of workforce development such as to share and evaluate the state of global research, academic capacity, workforce diversity and equality, development and evaluation mechanisms that will and quality assurance. support national leadership bodies and member organisations in the effective implementation of a 1.8 Educational research and evaluation agenda in needs-based pharmaceutical workforce development pharmacy needs strengthening and it is clear that roadmap guided by the Nanjing outcomes. better ways of evaluating the impact of technology- driven education need to be developed and used more 1.4 Data was collected from 21 countries around the routinely by education providers. world to better understand their national-level research, development and evaluation strategies 1.9 This report provides a starting point for describing our for the pharmaceutical workforce and how they are current global baseline in a broad context of workforce aligned with the PWDGs. The PWDGs are aimed to be and educational development. Similarly, within the a set of measurable, feasible and achievable goals. context of a valid global vision for transforming The ability to align national strategies with the goals the workforce we should be identifying our current show that they can be measurable. Collectively, the position, across all of the PWDGs, in order to plan for high alignment between current strategies, projects structured collective development. and initiatives demonstrate that the goals are also achievable. While progress towards achieving the 1.10 It is also clear that for some PWDGs, there is a wider PWDGs
Load more

Recommended publications
  • Doctor of Pharmacy (Pharm. D.) SCOPE & PLACEMENTS
    Doctor of Pharmacy (Pharm. D.) (6 Years Post Graduation with Prefix Doctor before your name) Importance, Scope and Placements in India & Abroad About Course Pharm.D. course is introduced by Govt. of India and Pharmacy Council of India, New Delhi in 2008 It was introduced with a vision for improvement of clinical pharmacy services in our country. It is the only pharmacy service which is in direct contact with patient health care system. The Pharm.D. program is a pre-Ph.D., post-graduate professional doctorate. After obtaining Pharm.D. degree, the candidate can put Dr. (Doctor) before his/her name. Duration: 06 years, divided in two phases: Phase-I (05 Years Study) and Phase-II (01 Year Internship/ Residency) Examination pattern: Annual Eligibility: Pass in 10+2 Science (Medical/ Non-Medical) or D.Pharmacy, eligible to get admission in first year of this course. In countries like USA, Australia, Canada etc., this course has central and pivotal role in the health care system. The course aims to prepare eligible candidates students in the management of patient medication therapy and improving patient outcomes. SCOPE & PLACEMENTS Pharm.D. candidates may work in the following fields: Scientist for Clinical Trials: A new drug undergoes various clinical trials on humans under the expertise of pharmacologists. Pharmacovigilance Scientist/Officer: Various companies like Quantum, Herron etc. recruit pharmacologists for the vigilance of various drugs used in the public domain for their new adverse drug effects or new indications etc. Clinical Research Organizations like Parexel, Herron etc. Research fellow in various research projects of government and private agencies.
    [Show full text]
  • We've Got Your Pre-Reg Year Covered
    We’ve got your pre-reg year covered Don’t forget RPS members receive at least 25% off, simply enter your membership number at the checkout. Order online at www.pharmpress.com/pre-registration Books to support you through Pharmacy Registration Clinical Pharmacy Pocket Assessment Questions Companion NEW EDITION Second edition Second edition Edited by Nadia Bukhari, Oksana Pyzik Edited by Alistair Howard Gray, Jane Wright, Lynn Bruce, Jennifer Oakley Written in compliance with the current GPhC registration exam guidelines, this essential title helps students prepare A handy pocket sized A-Z book that offers quick and reliable for their registration exam. With 400 brand new questions, answers to everyday pharmacy questions. This edition is it features single best answer, extended MCQs and extremely useful for trainees, whether you work in a hospital calculation questions. or community setting. ISBN: 978 0 85711 278 1 • £32 ISBN: 978 0 85711 157 9 • £32 Paperback • 180 x 100mm • 568pp • 2015 Paperback • 216 x 138mm • 224pp • Feb 2017 BNF Hospital Pre-registration March and September Pharmacist Training Joint Formulary Committee Aamer Safdar, Shirley Ip One of the essential references you will need to understand With tips, hints, past experiences and anecdotes from the and navigate ahead of your exam. Published each March authors in their roles as pre-registration tutors, this accessible and September, the BNF provides up-to-date guidance on book provides encouragement and guidance throughout the prescribing, dispensing and administering medicines. pre-registration process. It covers topics such as looking for It reflects current best practice as well as legal and your first job, making the transition from student to professional guidelines relating to the use of medicines.
    [Show full text]
  • Professionals and Academics Degrees in Pharmacy: “Understanding the Designation of Each
    International Journal of Pharmacy Teaching & Practices 2012, Vol.3, Issue 3, 281-282. Professionals and academics Degrees in Pharmacy: “Understanding the designation of each degree and knowing which degree to pursue for the right perspective future work.” Guy Armel Bounda School of Pharmacy,China Pharmaceutical University college or university that is usually awarded in Letter to Editor recognition of the recipient having either satisfactory completed a prescribed course of study.[9] The most Please cite this paper as: Guy Armel Bounda. Professionals and common academic degrees awarded today are academics Degrees in Pharmacy: “Understanding the designation of Bachelor’s, Master’s and Doctoral degrees. The each degree and knowing which degree to pursue for the right modern pharmacy profession has shifted perspective future work.” IJPTP, 2012,3(3),281-282 . considerably away from a product focus and towards Corresponding Author: a patient focus. To cope with these changes, and to meet the demand of the modern pharmacy Guy Armel Bounda profession, the pharmacy curriculum, especially in Clinical Pharmacy, the developed world, has evolved significantly. [6] School of Pharmacy China Pharmaceutical University In the western countries and in several 24# Tong Jia Xiang, Nanjing 210009 countries where their education system is based on P.R.China The United Kingdom or on The United States Email: [email protected] Educational system, BPharm (Bachelor of Letter Comment Pharmacy), MPharm (Master of Pharmacy) and PharmD (Doctor of Pharmacy) are the
    [Show full text]
  • Development and Current Status of Clinical Pharmacy Education in China
    American Journal of Pharmaceutical Education 2014; 78 (8) Article 157. REVIEW Development and Current Status of Clinical Pharmacy Education in China Ming Hu, PhD,a Gary Yee, PharmD,b Naitong Zhou, MS,a Nan Yang, PhD,a Xuehua Jiang, PhD,a and Donald Klepser, PhDb a West School of Pharmacy, Sichuan University, Chengdu, Sichuan Province, China b College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska Submitted October 24, 2013; accepted February 19, 2014; published October 15, 2014. Objective. To describe the current status and developing trend of clinical pharmacy education in China. Methods. Descriptive analysis of data and information about the clinical pharmacy specialty, pharmacy colleges, and curriculum from literature, college websites, and statistics from the Ministry of Health (MOH) and Ministry of Education (MOE) websites was conducted. Results. Clinical pharmacy programs were established in China in 1989 but developed more fully after 2006. In 2012, there were 30 pharmacy colleges with clinical pharmacy undergraduate programs, which included a bachelor’s degree in clinical pharmacy and a clinical pharmacy concentration within the BS programs of pharmacy or medicine. More than 40 colleges within the university system offer 4 types of master’s degree programs in clinical pharmacy. Five universities offer a PhD program in clinical phar- macy. Three postgraduate programs exist, which train hospital pharmacists and clinical pharmacists: the 312 year Hospital Pharmacist Standardized Training Program at Peking hospitals; the 1-year Clinical Pharmacist Training Program sponsored by the MOH; and the 2-year Clinical Pharmacist Residency Program provided by West China Hospital at Sichuan University. Conclusion. A growing clinical pharmacy education system has been established and has become an important subfield in Chinese pharmacy education.
    [Show full text]
  • Pharmacy Education in Australia with a Special Focus on Clinical Pharmacy Education
    JAASP http://www.aaspjournal.org Journal of Asian Association of Schools of Pharmacy 2019; 8: 1–6 © 2019 The Asian Association of Schools of Pharmacy Review Pharmacy education in Australia with a special focus on clinical pharmacy education Shu Chuen Li* Discipline of Pharmacy & Experimental Pharmacology, School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan, Australia Received February 7, 2019 ABSTRACT Revised March 15, 2019 Accepted March 25, 2019 In Australia, there are currently two types of pharmacy programs, a four-year Bachelor of Pharmacy program and a two-year graduate entry Master of Pharmacy Program, offered by * Corresponding author 18 Pharmacy schools. Completion of either degree together with other requirements is the Discipline of Pharmacy & Experimental current basis for registration to practice as a pharmacist. Pharmacology, School of Biomedical The quality of pharmacy education and training in Australia is regulated and monitored by Sciences & Pharmacy, University of Newcastle, Callaghan, NSW 2308, Australia several governmental and professional organizations to ensure its standard. E-mail: [email protected] Postgraduate pharmacy training is also available from several universities in Australia to equip practicing pharmacists with advanced knowledge and skill in clinical pharmacy. Overall, pharmacy education and training in Australia is of high quality and producing practicing pharmacists to fulfil the current need of the local healthcare system. However, the heightened expectation for pharmacist to contribute further in health care delivery will put pressure on pharmacy schools to be more proactive in updating their curricula to meet this need. Key words: pharmacy, education, clinical pharmacy, post graduate training, Australia pharmacy. Students could enter the course at any date and 1.
    [Show full text]
  • G20 Academic Regulation (Appendix) 2017/18
    G20 ACADEMIC REGULATION (APPENDIX) 2017/18 G20 The College has the authority to confer and revoke awards under the Charter and Statutes of King’s College London. All awards have regard to the provisions of the QAA UK Quality Code for Higher Education. Conferment and Revocation G20.1 Academic Board has the authority to award and revoke any degree, diploma, certificate or other award granted by the College in accordance with the Charter and Statutes of King’s College London. Conferment G20.2 The Assessment Boards, acting on the recommendations of their constituent Assessment Sub Boards, the Research Degrees Examination Board and the College Assessment and Standards Committee are the sole bodies having delegated authority to recommend the conferment of the awards for which they are responsible. G20.3 The only occasion when a decision relating to results ratified by the Assessment Board can be modified, is under the provisions of the academic appeals process. Revocations G20.4 Award type, award title or classification can be revoked and reissued, or an award can be revoked in its entirety. G20.5 A revocation may be applied: a) when there is satisfactory proof that there was an administrative error in the award made; b) when, subsequent to award, an Assessment Board takes into account information which was unavailable at the time its original decision was made; or c) following a recommendation by the Misconduct Committee or by an Inquiry Panel established to investigate allegations of research misconduct. Awards G20.6 The awards have regard to the provisions of the QAA’s UK Quality code for higher education and meet the following requirements specified for King’s College London degrees, diplomas and certificates: Undergraduate Certificates (level 4) G20.7 An Undergraduate Certificate is the equivalent of one year’s study of an undergraduate degree at level 4.
    [Show full text]
  • Annual Report 2019 TABLE of CONTENTS
    Hamdard University Islamabad Campus Annual Report 2019 TABLE OF CONTENTS Contents Page No The Founder 1 Message from Director General 3 Vision of Hamdard University 4 Mission of Hamdard University 4 Hamdard University Islamabad Campus 4 Highlights of Year 2019 5 HUIC Organizational Chart 6 Academic Performance 7 Admissions 2019 7 Recognition of Academic Programs 7 Number of Graduates 8 Library at HUIC 9 Office of Student Affairs 12 Hamdard Institute of Management Sciences 15 Hamdard Institute of Engineering and Technology 21 Hamdard Institute of Pharmaceutical Sciences 27 HAMDARD UNIVERSITY ISLAMABAD CAMPUS ANNUAL REPORT 2019 The Founder Shaheed Hakim Mohammed Said (1920-1998) established Hamdard Pakistan in 1948. Within a few years, the herbal medical products of Hamdard became household names. The phenomenal success of Hamdard products is a legendary part of the business history of Pakistan. The name Hamdard however acquired a still wider meaning, when Hakim Mohammed Said founded Hamdard University in 1991. The establishment of a university which could enliven the intellectual tradition of the educational institutions of the golden era of Muslim civilization had always been his most cherished dream.In fact it was the central point towards which all his endeavours were directed. The actual appearance of the university was just the culmination of a long dedicated and continued effort spanning his whole life. However, apart from being a great educational leader, Hakim Mohammed Said was also one of the finest exponents of eastern medicine, who had treated millions of patients from all over the world including Pakistan, Europe,Africa and the Middle East by the time of his martyrdom (Shahadat) in October 1998.
    [Show full text]
  • Self Evaluation Report and Description Tartu School of Pharmacy 2008
    University of Tartu Faculty of Medicine Department of Pharmacy SELF-EVALUATION REPORT for the accreditation of curricula : 80419 (8896212) Pharmacy (Bachelor and Master`s integrated studies) 2707 (8505202) Pharmacy (Doctoral studies) 80361 (8896212) Pharmacy (Doctoral studies) Approved by: Head of the Working Group Prof. Peep Veski …………………………….. Signature Date Dean of the Faculty of Medicine Prof. Toomas Asser ……………………………… Signature Date Vice Rector for Prof. Birute Klaas ……………………………… Academic Affairs Signature Date Tartu 2008 1 TABLE OF CONTENT DESCRIPTION OF THE PROCESS OF COMPILING THE SELF-EVALUATION REPORT 1 1. INTRODUCTION 1.1. THE MISSION OF THE UNIVERSITY OF TARTU 2 1.2. BRIEF HISTORY OF THE UNIVERSITY OF TARTU 2 1.3. THE ESTONIAN SYSTEM OF HIGHER EDUCATION 2 1.4 THE STRUCTURE OF THE UNIVERSITY OF TARTU 3 1.5. PRINCIPLES AND ORGANISATION OF QUALITY ASSURANCE AT THE UNIVERSITY 4 1.6. ORGANIZATION AND MANAGEMENT OF THE FACULTY OF MEDICINE 5 1.7. ORGANIZATION AND MANAGEMENT OF THE DEPARTMENT OF PHARMACY 7 2. PHARMACY EDUCATION IN ESTONIA 8 3. THE OBJECTIVES OF THE DEPARTMENT OF PHARMACY 8 4. DESCRIPTION OF THE CURRICULA 9 4.1. HISTORY OF TEACHING OF PHARMACY AT THE UNIVERSITY OF TARTU 9 4.2. CHARACTERISATION OF CURRICULUM: PHARMACY MASTER CURRICULUM 9 4.3. OPENING, MANAGING AND CHANGING OF THE CURRICULUM 11 4.4. CHARACTERISATION OF CURRICULUM: DOCTORAL STUDIES 12 4.5. THE CURRICULUM: STRONG SIDES 12 4.6. THE CURRICULUM: WEAK SIDES 13 4.7. ACTION PLAN 13 4.8. TRAINING PROCESS 13 4.9. TRAINING METHODS 14 4.10. TRAINING PROCESS: STRONG SIDES 16 4.11.
    [Show full text]
  • Department of Pharmacy & Pharmacology
    Department of Pharmacy & Pharmacology Pre-entry Guide 2019-20 for Master of Pharmacy (MPharm) and Master of Pharmacy (MPharm) with integrated pre-registration year Name: …………………………………………. Dear Student, Congratulations on passing your exams and achieving the necessary qualifications to enter the Department of Pharmacy & Pharmacology at the University of Bath! You can be confident that you are embarking on a degree programme which is widely respected in the UK and further afield, and which will give you a strongly positive start to your chosen career in pharmacy. It is my responsibility as Director of Teaching, and MPharm Director of Studies, to ensure that our Department and its academic staff provide you with every opportunity to achieve your potential. We do this primarily by designing integrated MPharm programmes, in which core pharmaceutical sciences, pharmacology and biomedical sciences are taught in a way that emphasises their importance to clinical pharmacy practice. Our MPharm programmes undergo regular review and updates, both to keep their content in line with recent scientific and clinical research, and to take advantage of technological developments so that at least some of that accumulated information can be made available in an easily digestible form to you. A brief outline of the first year of your MPharm programme is provided in this booklet, together with some instructions on what we would like you to do before arriving in Bath to commence your studies. However, the most important point that I wish to emphasise is that, at University, your success (or otherwise!) is much more in your hands than it is in ours.
    [Show full text]
  • Curriculum Vitae 4 Pages
    Curriculum Vitae (short version, 4 pages) 1. FULL NAME Vincenzo Cerullo (ResearchID: B-9075-2015; ORCID: 0000-0003-4901-3796) 2. OTHER INFORMATION Citizenship: Italian Office address: Biocenter 2, Viikinkaari 5E, 00790 Helsinki, Finland Home Address: Uimarinpolku 10C 15, 00330 Helsinki, Finland Marital Status: Married, two children (Victor, 6 and Nicole, 2) 3. EDUCATION AND DEGREE AWARDED 23/10/1998 Master of Pharmacy and Pharmaceutical Chemistry (5 years), score 110/110 cum laude University of Naples “Federico II”. Title of the Thesis: Crellastatin A: A Cytotoxic Bis-Steroid Sulfate from the Vanuatu Marine Sponge Crella sp. Supervisors: Professors Luigi Minale and Mariavaleria D’Auria 3 Jun 1999 Board of Pharmacy 17 Jun 2004 Doctor in Biotechnology, University of L’Aquila and University of Naples “Federico II”. Title of the thesis: Development of Helper-dependent Adenoviral Vectors for gene therapy of Atherosclerosis. Supervisors: Professor Lucio Pastore and Professor Fabrizio Pane. 13 May 2011 Docent (equivalent to adjunct professor or senior lecturer) of Experimental Virology, University of Helsinki. 4. OTHER EDUCATION AND TRAINING, QUALIFICATIONS AND SKILLS - Pedagogy education at University of Helsinki (35ECTs) teaching in higher Education - Clinical trials development and clinical research – ASGCT 5. LINGUISTIC SKILLS Italian: mother tongue English: fluent Spanish: good Finnish: entry (second level Helsingin Aikuisopisto, training still on-going) Swedish: good (wife and son Swedish-speaking) 6. CURRENT POSITION 16/09/2012 Tenure-track
    [Show full text]
  • Previous Versions
    BMJ Open is committed to open peer review. As part of this commitment we make the peer review history of every article we publish publicly available. When an article is published we post the peer reviewers’ comments and the authors’ responses online. We also post the versions of the paper that were used during peer review. These are the versions that the peer review comments apply to. The versions of the paper that follow are the versions that were submitted during the peer review process. They are not the versions of record or the final published versions. They should not be cited or distributed as the published version of this manuscript. BMJ Open is an open access journal and the full, final, typeset and author-corrected version of record of the manuscript is available on our site with no access controls, subscription charges or pay-per-view fees (http://bmjopen.bmj.com). If you have any questions on BMJ Open’s open peer review process please email [email protected] BMJ Open Digital Health Literacy Intervention to Support Maternal, Child and Family Health in Primary Healthcare Settings of Pakistan during the Age of Coronavirus: Study Protocol for a Randomized Controlled Trial ForJournal: peerBMJ Open review only Manuscript ID bmjopen-2020-045163 Article Type: Protocol Date Submitted by the 25-Sep-2020 Author: Complete List of Authors: Jafree, Sara; Forman Christian College, Department of Sociology Bukhari, Nadia; University College London, School of Pharmacy Muzamill, Anam; Forman Christian College, Department of Mass Communications
    [Show full text]
  • Pharmacy Registration Assessment Questions, Edition 2
    ADVANCED BOOK INFORMATION PHARMACEUTICAL PRESS – Textbook ISBN: 978 0 85711 278 1 Paperback Pub date: February 2017 Extent: 224 pages Format: 216 x 138mm Price: £32.00 / $45.00TBC Pharmacy Registration Assessment Book Cover TBA Questions Edition: 2 Series Editor(s): Nadia Bukhari, Senior Teaching Fellow in Pharmacy Practice & Pre- Registration Co-ordinator at UCL School of Pharmacy, London. Contributor(s): Oksana Pyzik, Ryan Hamilton, Amar Iqbal and Babir Malik. Readership: UK pharmacy students in their pre-registration year Te Product Summary: Pharmacy Registration Assessment Questions is written and structured and developed around the current GPhC registration exam guidelines. Comprising of 400 questions, the book covers all sections such as BO5, EMQ, Classification, and Calculation, which will allow students to practice questions in the new format much before the examinations. All questions are based on BNF72. Unique Benefits: - Credibility: Nadia Bukhari (now editor) is a former question writer for the registration exam - 400 questions, updated to match the BNF, BNF for Children and Medicines, Ethics and Practice The book is divided into the following sections: Best of 5 – Simple best answer questions Calculations questions Extended Multiple Choice Questions Format Availability: Book – print, ISBN: 978 0 85711 278 1, Paperback, Pub date: February 2017, Extent: 224 pages, Format: 216 x 138mm, Colour: Mono Price: £32.00 / $45.00 TBC eBook platforms: TBC www.pharmpress.com www.twitter.com/pharmpress www.facebook.com/pharmpress ADVANCED
    [Show full text]